Kimberly Schatz Martin, DO
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · County of Santa Clara · Intermountain Medical Group Denver LLC
Hospitals listed: Intermountain Health Good Samaritan Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Martin’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- Florida OS14429Osteopathic Physician · since 2017 · expires 2028-03-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
5 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- Internal Medicine
- Pediatrics
Education
- Lake Erie College of Osteopathic · DO2010–2014Medical school
- All-India Institute of Medical · MD1956–1962Medical school
Residency and fellowship
- Northside Hospital, INTERNAL MEDICINESt. Petersburg, FL · 2014–2017
- University Medical Center-Ufhsc/, Pediatrics***, FL · 1969–1972
- Montefiore M C-H&L, Pediatrics***, NY · 1967–1967
- Bombay University, Pediatrics***, IN · 1962–1967
- College of Physicians and Sueeons, Pediatrics***, IN · 1962–1965
What else the board holds
Hospitals they may admit to
Where the clinician told their state board they may admit and treat patients.
- Baptist Medical Center · FL
- Memorial Hospital Jacksonville · FL
- St. Vincents Medical Center · FL
Also licensed in
States the clinician told their board they are also licensed in. Only the states we check are verified.
Florida
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan Medical Center LLCLafayette, COAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Intermountain Healthcare, which runs 33 hospitals in 4 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.294, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Medical Center LLC
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.294 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0 to 2.01) · 337 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.52 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 169.74 (109.61 to 229.86) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.3 · 42 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.8 · 75 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 108 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 155 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 2,654 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.03 to 0.48) · 1,851 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.47) · 1,797 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.13 (0.8 to 5.47) · 512 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.32) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.4 (0.75 to 4.04) · 489 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.61 (0 to 16.79) · 166 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.81 (0.65 to 8.97) · 149 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 107 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.73 (0 to 1.71) · 1,534 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 98 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.412 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.734 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.583 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.586 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 155 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 534 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -28.2 · 79 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.8 · 112 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 532 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.3 (4.1 to 9.5) · 33 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (6.9 to 14.3) · 33 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 73 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 174 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.3 to 18.3) · 297 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 158 cases | No different | Jan 2024 – Dec 2024 |
What patients said (870 patients answered, 27% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$72,408
Medicare paid this office $72,408 for 389 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 272 | $40,495 | $60 |
| Hospital discharge day management, more than 30 minutes | 231 | $20,384 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $6,537 | $133 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $2,710 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,587 | $88 |
Who their Medicare patients are
389 Original Medicare patients in 2024. Average age 78 · Under 65 5% · 85 and older 28% · Women 59% · Also on Medicaid 10% · Health risk score 2.69. Above the middle of the specialty; the typical hospitalist clinician is at 2.49.
Conditions among them: High blood pressure 75% · Coronary heart disease 65% · Chronic kidney disease 55% · Depression 51% · Heart failure 49% · Diabetes 48% · Atrial fibrillation 42% · COPD 33% · Dementia 31% · Stroke 29% · Cancer 24%.
The office billed $235,410, Medicare allowed $92,407 and paid $72,408; for 1,021 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 389 | 1,021 | 78 | 2.69 | $235,410 | $72,408 |
| 2023 | 391 | 1,025 | 78 | 2.23 | $225,076 | $74,504 |
| 2022 | 400 | 1,068 | 78 | 2.40 | $211,561 | $74,029 |
| 2021 | 392 | 1,075 | 78 | 2.51 | $192,140 | $75,064 |
| 2020 | 410 | 1,092 | 76 | 2.43 | $212,036 | $83,207 |
| 2019 | 331 | 919 | 76 | 2.64 | $212,758 | $68,832 |
| 2018 | 341 | 1,026 | 75 | 2.85 | $255,119 | $78,865 |
| 2017 | 135 | 416 | 73 | 2.50 | $97,799 | $32,297 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 263 | $39,653 | $62 |
| Hospital discharge day management, more than 30 minutes | 225 | $20,202 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $8,265 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $2,767 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,041 | $102 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $1,406 | $38 |
2022: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 240 | $36,881 | $56 |
| Hospital discharge day management, more than 30 minutes | 136 | $11,023 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $10,880 | $149 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $5,361 | $80 |
| Initial hospital observation care per day, typically 70 minutes | 29 | $4,175 | $144 |
| Hospital discharge day management, 30 minutes or less | 28 | $1,588 | $57 |
| Hospital observation care on day of discharge | 24 | $1,434 | $57 |
| Follow-up observation care per day, typically 25 minutes | 17 | $1,252 | $57 |
2021: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 240 | $36,568 | $56 |
| Hospital discharge day management, more than 30 minutes | 183 | $15,619 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $8,895 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 79 | $7,823 | $79 |
| Initial hospital observation care per day, typically 70 minutes | 17 | $2,484 | $146 |
| Hospital observation care on day of discharge | 38 | $2,134 | $56 |
| Follow-up observation care per day, typically 25 minutes | 11 | $635 | $58 |
2020: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 219 | $30,166 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 139 | $15,954 | $83 |
| Hospital discharge day management, more than 30 minutes | 174 | $14,781 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $11,730 | $163 |
| Initial hospital observation care per day, typically 70 minutes | 27 | $4,078 | $151 |
| Hospital observation care on day of discharge | 46 | $2,409 | $52 |
| Follow-up observation care per day, typically 25 minutes | 15 | $1,060 | $59 |
2019: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 148 | $22,620 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 149 | $18,257 | $57 |
| Hospital discharge day management, more than 30 minutes | 149 | $12,897 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $4,868 | $157 |
| Hospital observation care on day of discharge | 60 | $3,366 | $55 |
| Initial hospital observation care per day, typically 70 minutes | 20 | $2,684 | $134 |
| Critical care, first 30-74 minutes | 12 | $2,154 | $180 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 15 | $669 | $42 |
2018: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 163 | $20,582 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 122 | $19,093 | $83 |
| Hospital discharge day management, more than 30 minutes | 203 | $17,648 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $7,015 | $159 |
| Hospital observation care on day of discharge | 65 | $3,801 | $56 |
| Initial hospital observation care per day, typically 70 minutes | 21 | $3,135 | $149 |
| Critical care, first 30-74 minutes | 14 | $2,373 | $169 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,209 | $101 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 27 | $1,143 | $42 |
| Initial hospital observation care per day, typically 50 minutes | 11 | $1,031 | $94 |
| Follow-up observation care per day, typically 25 minutes | 17 | $995 | $55 |
2017: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 84 | $11,859 | $58 |
| Hospital discharge day management, more than 30 minutes | 60 | $5,210 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $5,000 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,703 | $161 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,301 | $110 |
| Hospital observation care on day of discharge | 13 | $753 | $58 |
Medicaid work
$775 in 2022
Medicaid paid $775 for 27 billed services this clinician did in 2022, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 27 | $775 |
| 2022 | 27 | 1 | 13 | $775 |
| 2020 | 59 | 2 | 21 | $676 |
| 2019 | 82 | 3 | 16 | $4,156 |
See the largest Medicaid services in earlier years
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 38 | $676 |
| Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | 21 | $0 |
2019
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 36 | $2,553 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 33 | $1,275 |
| OBSERVATION CARE DISCHARGE | 13 | $329 |
Drugs they prescribed that Part D paid
$22,516
Pharmacies billed $22,516 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (19 of 451) in 2024. At or below the middle of the specialty; the typical hospitalist clinician is at 4%.
394 generic and 57 brand-name prescriptions · $22,516 in drug cost · 177 antibiotic prescriptions to 99 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 14 | $8,585 | $613 |
| Vancomycin | 54 | $1,617 | $30 |
| Cefdinir | 39 | $324 | $8 |
| Metoprolol | 20 | $201 | $10 |
| Atorvastatin | 13 | $165 | $13 |
See all 12 drugs
| Eliquis | 14 | $8,585 | $613 |
| Vancomycin | 54 | $1,617 | $30 |
| Cefdinir | 39 | $324 | $8 |
| Metoprolol | 20 | $201 | $10 |
| Atorvastatin | 13 | $165 | $13 |
| Pantoprazole | 25 | $158 | $6 |
| Ciprofloxacin | 15 | $90 | $6 |
| Amoxicillin-Clavulanate Potass | 13 | $90 | $7 |
| Azithromycin | 17 | $57 | $3 |
| Furosemide | 13 | $40 | $3 |
| Prednisone | 14 | $36 | $3 |
| Hydrocodone-Acetaminophen | 12 | $34 | $3 |
Year by year
| 2024 | 451 | 188 | 4% (19) | 13% | $22,516 |
| 2023 | 357 | 160 | 5% (19) | 10% | $15,561 |
| 2022 | 259 | 128 | 5% (14) | 7% | $12,905 |
| 2021 | 286 | 120 | 5% (13) | None | $8,308 |
| 2020 | 267 | 111 | None | 8% | $10,070 |
| 2019 | 423 | 194 | 4% (15) | 9% | $17,328 |
| 2018 | 539 | 232 | 5% (29) | None | $34,120 |
| 2017 | 242 | 81 | None | 21% | $15,444 |
| 2016 | 62 | 21 | 0% (0) | None | $3,669 |
| 2015 | 51 | 23 | 0% (0) | 27% | $2,705 |
| 2014 | 24 | None | 0% (0) | None | $638 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Vancomycin | 34 | $2,471 | $73 |
| Cefdinir | 31 | $410 | $13 |
| Pantoprazole | 23 | $189 | $8 |
| Metronidazole | 14 | $81 | $6 |
| Prednisone | 14 | $38 | $3 |
| Furosemide | 13 | $32 | $2 |
2022: 2 drugs
| Cefdinir | 16 | $261 | $16 |
| Pantoprazole | 19 | $151 | $8 |
2021: 6 drugs
| Tamsulosin | 14 | $336 | $24 |
| Montelukast | 11 | $322 | $29 |
| Cefdinir | 17 | $215 | $13 |
| Lisinopril | 14 | $188 | $13 |
| Pantoprazole | 22 | $182 | $8 |
| Prednisone | 11 | $20 | $2 |
2020: 4 drugs
| Cefdinir | 15 | $268 | $18 |
| Lisinopril | 12 | $262 | $22 |
| Pantoprazole | 24 | $249 | $10 |
| Prednisone | 30 | $218 | $7 |
2019: 7 drugs
| Cefdinir | 36 | $462 | $13 |
| Prednisone | 41 | $269 | $7 |
| Doxycycline Hyclate | 21 | $247 | $12 |
| Pantoprazole | 16 | $173 | $11 |
| Azithromycin | 18 | $108 | $6 |
| Ciprofloxacin | 11 | $68 | $6 |
| Lisinopril | 20 | $65 | $3 |
2018: 14 drugs
| Serevent Diskus | 11 | $4,417 | $402 |
| Doxycycline Hyclate | 18 | $455 | $25 |
| Cefdinir | 27 | $353 | $13 |
| Atorvastatin | 21 | $171 | $8 |
| Pantoprazole | 16 | $145 | $9 |
| Gabapentin | 12 | $134 | $11 |
| Prednisone | 30 | $121 | $4 |
| Doxycycline Monohydrate | 12 | $102 | $8 |
| Ciprofloxacin | 17 | $88 | $5 |
| Famotidine | 12 | $83 | $7 |
| Oxycodone-Acetaminophen | 12 | $77 | $6 |
| Cephalexin | 11 | $68 | $6 |
| Azithromycin | 13 | $67 | $5 |
| Furosemide | 13 | $45 | $3 |
2017: 1 drug
| Furosemide | 11 | $49 | $4 |
2016: 1 drug
| Hydrocortisone | 11 | $96 | $9 |
Money from drug and device companies
$122 in 2025
| 2025 | 2 | 5 | None | $122 |
| 2024 | 4 | 10 | None | $233 |
| 2023 | 7 | 10 | None | $211 |
| 2022 | 3 | 10 | None | $200 |
| 2021 | 5 | 11 | None | $167 |
| 2020 | 6 | 6 | None | $118 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 5 published payments
| Pfizer | Meals · 2025-07-25 | Eliquis | $25 |
| Abbvie | Meals · 2025-07-11 | Emblaveo | $30 |
| Pfizer | Meals · 2025-04-24 | Eliquis | $20 |
| Pfizer | Meals · 2025-01-17 | Vyndamax | $27 |
| Pfizer | Meals · 2025-01-11 | Eliquis | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $233
| Pfizer | Eliquis | $128 | 6 payments
|
| Abbvie | Avycaz | $54 | 2 payments
|
| Aimmune Therapeutics | Vowst | $29 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $22 | 1 payment
|
2023: $211
| E.R. Squibb & Sons L.L.C. | Eliquis | $41 | 2 payments
|
| AbbVie | Dalvance | $40 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $36 | 2 payments
|
| Alexion Pharmaceuticals | Ultomiris | $30 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $22 | 1 payment
|
| Pfizer | Eliquis | $22 | 1 payment
|
| Aimmune Therapeutics | Vowst | $19 | 1 payment
|
2022: $200
| Abbvie | Dalvance | $81 | 4 payments
|
| Pfizer | Eliquis | $66 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $52 | 3 payments
|
2021: $167
| Janssen Pharmaceuticals | Xarelto | $57 | 4 payments
|
| Pfizer | Eliquis | $48 | 3 payments
|
| AbbVie | Dalvance | $37 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $14 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $11 | 1 payment
|
2020: $118
| Ucb | Vimpat | $36 | 1 payment
|
| Amgen | Repatha | $22 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $18 | 1 payment
|
| Pfizer | Eliquis | $16 | 1 payment
|
| Allergan | Dalvance | $14 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $12 | 1 payment
|
Professional record
- NPI
- 1851536262
- Licence
- FL CH9670, FL OS14429Florida OS14429: Active
- Trained
- Lake Erie College of Osteopathic Medicine, Bradenton, 2014
- Group
- County of Santa Clara · Intermountain Medical Group Denver LLC
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- FL 021951400
- Taxonomy
- Hospitalist (208M00000X); Internal medicine (207R00000X)
- Mailing address
- Po Box 746638, Atlanta, GA, 30374
- NPI first listed
- 2008-12-15
- NPI last updated
- 2026-08-25
- NPI record certified
- 2026-08-25
This is when the NPI record was last certified, not a medical board exam.